![Walter Menzel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Walter Menzel
Founder at Prostate Management Diagnostics, Inc.
Net worth: 12 862 $ as of 2024-06-29
Profile
Walter B.
Menzel is the founder of Prostate Management Diagnostics, Inc., Peter Michael Foundation.
He is currently the President of WM Group.
Previously, he worked as an Independent Director at Cyanotech Corp.
and as a Senior Vice President at McCann-Erickson USA, Inc. Mr. Menzel's education includes a graduate degree in MBA from Stanford University and an undergraduate degree from the University of Wisconsin.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CYANOTECH CORPORATION
0.57% | 2023-06-25 | 39,455 ( 0.57% ) | 12 862 $ | 2024-06-29 |
Walter Menzel active positions
Companies | Position | Start |
---|---|---|
WM Group | President | - |
Peter Michael Foundation
![]() Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Founder | - |
Prostate Management Diagnostics, Inc.
![]() Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Founder | - |
Former positions of Walter Menzel
Companies | Position | End |
---|---|---|
McCann-Erickson USA, Inc.
![]() McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
CYANOTECH CORPORATION | Director/Board Member | - |
Training of Walter Menzel
University of Wisconsin | Undergraduate Degree |
Stanford University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CYANOTECH CORPORATION | Health Technology |
Private companies | 4 |
---|---|
WM Group | |
Peter Michael Foundation
![]() Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Commercial Services |
Prostate Management Diagnostics, Inc.
![]() Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Health Technology |
McCann-Erickson USA, Inc.
![]() McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Walter Menzel